T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.

NCT06474676 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Soft-tissue Sarcoma

Interventions

DRUG: Cyclophosphamide
DRUG: T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy

Sponsor

M.D. Anderson Cancer Center